scispace - formally typeset
E

Erhard Haus

Researcher at University of Minnesota

Publications -  138
Citations -  6794

Erhard Haus is an academic researcher from University of Minnesota. The author has contributed to research in topics: Circadian rhythm & Chronobiology. The author has an hindex of 43, co-authored 138 publications receiving 6410 citations. Previous affiliations of Erhard Haus include Regions Hospital & HealthPartners.

Papers
More filters
Journal ArticleDOI

Clinical Chronobiology and Chronotherapeutics with Applications to Asthma

TL;DR: Recent advances in medical chronobiology and chronotherapeutics are discussed and their relevance to clinical medicine in general and the management of asthma in particular is discussed.
Journal Article

Resonance of about-weekly human heart rate rhythm with solar activity change.

TL;DR: In several human adults, certain solar activity rhythms may influence an about 7-day rhythm in heart rate, which corresponds to about-weekly features in solar activity and/or relates to a sunspot cycle.
Book ChapterDOI

Biological rhythms, drug delivery, and chronotherapeutics

TL;DR: This chapter reviews circadian and other period biological rhythm dependencies of the pathophysiology of disease and pharmacology of medications as the basis for chronotherapeutics and development of time-modulated drug-delivery systems.
Journal Article

Close reproduction by different laboratories of characteristics of circadian rhythm in 1-beta-D-arabinofuranosylcytosine tolerance by mice.

TL;DR: There was close agreement in the results obtained by the 2 laboratories in mean survival time; the percentage of survivors when mice were treated according to certain of the selected sinusoidal schedules was much greater than for mice treated on the homeostatic schedule.
Journal ArticleDOI

Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.

TL;DR: It is suggested that melatonin or a melatonin receptor agonist may be useful biologic additions in the treatment of some forms of TNBC, especially in AA who generally show a more aggressive course of their disease.